Nilsine Partners, LLC Astrazeneca PLC Transaction History
Nilsine Partners, LLC
- $934 Billion
- Q4 2024
A detailed history of Nilsine Partners, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Nilsine Partners, LLC holds 9,037 shares of AZN stock, worth $623,191. This represents 0.06% of its overall portfolio holdings.
Number of Shares
9,037
Previous 9,109
0.79%
Holding current value
$623,191
Previous $710 Million
16.57%
% of portfolio
0.06%
Previous 0.09%
Shares
7 transactions
Others Institutions Holding AZN
# of Institutions
1,334Shares Held
476MCall Options Held
5.39MPut Options Held
3.75M-
Price T Rowe Associates Inc Baltimore, MD62.9MShares$4.34 Billion0.56% of portfolio
-
Primecap Management CO Pasadena, CA42MShares$2.89 Billion2.45% of portfolio
-
Wellington Management Group LLP Boston, MA37.2MShares$2.57 Billion0.52% of portfolio
-
Capital International Investors Los Angeles, CA36.8MShares$2.54 Billion0.57% of portfolio
-
Franklin Resources Inc San Mateo, CA19.1MShares$1.32 Billion0.45% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $214B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...